AzTrials
AzTrials

AmputeesNCT02875197

Comparing Running-Specific and Traditional Prostheses During Running: Assessing Performance and Risk

An observational study of Amputees and Running With Prosthesis, run by Regis University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to provide clinically, administratively, and field-relevant objective running outcomes by directly comparing running biomechanics of individuals with lower extremity amputation (ILEA) using RSPs (Running Specific Prostheses) and traditional prostheses. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Amputees, Running With Prosthesis
What is being tested?
Running on a treadmill at 6 different speeds
How many people
40 participants
Where
1 siteUnited States
Study dates
Aug 2016to Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Up to twenty subjects with unilateral transtibial amputations will be recruited from the military, veteran, and civilian populations. Civilian individuals with lower extremity amputation (ILEA) will be recruited who match the age range of military service members commonly sustaining injuries resulting in amputation. Up to twenty able-bodied sex, age, height, and weight-matched subjects will serve as a control group to provide normative data for comparison.

Who may be able to join

  • Subjects with amputation must have a unilateral, transtibial amputation and must have been prescribed a running-specific prosthesis
  • Subject with amputations resulting from trauma, congenital reasons, or cancer treatment. If due to cancer, cancer must be in remission or subjects must not be undergoing treatments that could affect their gait function
  • Subjects with amputation must be cleared to run by a physician
  • Subjects with amputation must have at least 4 months experience using a running-specific prosthesis
  • All subjects must be between the ages of 18 and 50 years
  • Males and females who meet the inclusion/exclusion criteria are eligible to participate

Who cannot join

  • Subjects with any injury, affliction, or comorbidities to the limb(s) (other than the amputation) that impairs the gait pattern
  • Women who are pregnant, as pregnancy can affect the gait pattern
  • Amputations resulting from dysvascular disease as this may affect their gait function
  • Amputations resulting from cancer treatment where the subject is still undergoing treatment that may affect their gait function

Trial locations and contacts

1 site in 1 country.

Brian Baum, Ph.D. contact

303-964-6791

bbaum@regis.edu

United States1 site, 1 recruiting
  • Regis University

    Denver, Colorado, 80221

    Brian Baum, Ph.D., 303-964-6791, bbaum@regis.edu

    Recruiting

Other trials in United States

About this study

The purpose of this research is to provide clinically, administratively, and field-relevant objective running outcomes by directly comparing running biomechanics of individuals with lower extremity amputation (ILEA) using RSPs (Running Specific Prostheses) and traditional prostheses. Within this purpose, the project has two specific aims:

Specific Aim 1: To compare RSPs and traditional prostheses with respect to running ability and performance

Read more

Specific Aim 2: To compare RSPs and traditional prostheses with respect to injury risks associated with running

Hypothesis 1a: RSPs will outperform traditional prostheses at all velocities as measured by kinetic data (ground reaction forces, joint powers, joint and limb work) and 50m dash time.

Hypothesis 1b: ILEA intact limbs and able-bodied control limbs will outperform residual limbs with RSPs and traditional prostheses at all velocities as measured by kinetic data.

Hypothesis 2: Running with RSPs will show reduced acute and chronic injury risks compared to traditional prostheses at all velocities as measured by loading rates, EMG amplitudes, lumbopelvic kinematics, and modeled joint loads.

Read the detailed description
  1. BACKGROUIND

Current knowledge and understanding of individuals with lower extremity amputations (ILEA) when running are limited with respect to biomechanical performance and injury risks. ILEA are able to run with both running-specific prostheses (RSPs) and traditional prostheses; however, direct comparisons of subjects running with each of these prosthetic designs do not exist. The reported literature examining one design or the other often do not have participants running at the same velocities. Additionally, when running velocities are similar between studies, the same variables are rarely investigated. This makes comparisons between RSPs and traditional prostheses exceedingly difficult, and drawing conclusions on both performance and injury risk is virtually impossible. Furthermore, no ILEA running studies to date have investigated muscle activities, nor have running simulations of musculoskeletal models been generated. These major gaps in research substantially limit the understanding of both performance and injury risk of ILEA running with different prosthetic designs. Gaining this knowledge will directly inform clinicians and administrators within the Department of Defense and Veterans Administration systems on prosthesis prescription for running at a range of speeds as well as for return to duty scenarios. Therefore, the proposed study will utilize motion capture, muscle activity, and musculoskeletal modeling techniques to directly compare performance and injury risks of ILEA running with both RSPs and traditional prostheses across a range of speeds. The investigators will also capture an able-bodied control group for normative comparisons. In doing so, this project directly attends to the OPORA's goals and needs at multiple levels.

  1. RESEARCH STRATEGY:

Subjects Twelve subjects with unilateral transtibial amputations will be recruited from the military, veteran, and civilian populations. Twelve able-bodied sex, age, height, and weight-matched subjects will serve as a control group to provide normative data for comparison. All subjects must provide their informed consent prior to beginning any portion of the study and will have the option to discontinue the study at any time without penalty. All subjects must complete the Physical Activity Readiness Questionnaire (PAR-Q) prior to beginning the experiment. If subjects fail this questionnaire (by responding "yes" to any of the 7 questions), they will not be allowed to participate in the study until they provide documentation from a physician clearing them to participate.

Experimental Procedures A randomization computer program will determine the order of prosthetic foot conditions (RSP or traditional) for the ILEA subjects. All subjects (Controls and ILEA) will undergo 3D running analysis on an instrumented treadmill. A motion capture system will collect kinematic data (i.e. limb positions; joint angles, velocities, accelerations) at 200 Hz from reflective markers placed on specific body landmarks. On the amputated limb, the shank cluster will be placed laterally on the socket and a marker will be placed at the distal tip of the socket to define the long axis of the residual shank segment. For the RSP conditions, eight additional markers will be placed on the prosthesis keel. The marker on the most acute point of the prosthesis will define the prosthetic limb "ankle" joint. For the traditional prosthesis conditions, markers will be placed similarly to the intact foot.

An instrumented treadmill will collect ground reaction force (GRF) data at 1000 Hz from force platforms imbedded in the treadmill. Kinematic and ground reaction force data will be combined and standard inverse dynamics techniques will be used to calculate joint kinetic data (i.e. forces, moments, powers, and work) using Visual3D (C-Motion, Germantown, MD) software.

Muscle activation data will be collected at a sampling frequency of 2000 Hz using surface electromyography (EMG) from six bilateral hip and trunk muscles. Disposable pre-gelled silver-silver chloride (Ag-AgCl) electrodes will be placed over bilateral gluteus medius, gluteus maximus, rectus femoris, biceps femoris, lumbar erector spinae, internal oblique, and external oblique muscles. Maximal voluntary isometric contractions (MVIC) will be obtained for normalization purposes using manual resistance applied in standardized positions.

All subjects (ILEA using RSPs, ILEA using traditional prosthesis, and Controls) will run at six prescribed speeds (2.5, 3.0, 3.5, 4.0, 5.0, 6.0 m/s) on a treadmill, presented in randomized order. ILEA subjects will complete all speed conditions wearing both their RSP and traditional prosthetic foot. As mentioned earlier, the prosthesis order will be randomized, but all speed conditions will be completed in one prosthesis prior to changing into the second prosthesis condition. This will save time and maintain a similar prosthetic fit between speed conditions. The study protocol requires that every subject runs at the same 6 specific speeds identified above. Each treadmill speed condition will take approximately 30 seconds, or the time needed for subjects to stabilize their gait at the speed and a collection of 10 consecutive strides to be collected. At least 2 minutes rest will be provided between each speed condition, and subjects can take more rest if needed.

After completing the treadmill trials, subjects will complete 3x50m dashes in each foot condition to determine maximum speed. Again, at least 2 minutes rest will be provided between each effort, and subjects can take more rest if needed. The order of prosthesis use will also be randomized for this test, but all three dashes will be completed consecutively for each prosthesis condition.

To evaluate performance while running, the primary outcome measures being evaluated will include peak joint powers; concentric, eccentric and total joint and limb work; average vertical and Anterior and Posterior (AP) GRFs; vertical and AP GRF impulses; and 50m dash time/speed. To evaluate injury risk while running, the primary outcome measures being evaluated will include average GRF magnitudes and loading rates, asymmetry in GRFs and joint moments, normalized EMG amplitudes, lumbopelvic kinematics, and peak and average joint contact forces over stance. Data for these measures will be collected for all subjects and then compared among the three groups (ILEA with RSPs, ILEA with Traditional Prosthesis, and Controls). No intervention will be offered to any subject and no follow-up to assess biomedical and/or health outcomes will be conducted.

Electromyography Signal Analysis Raw EMG data will be demeaned, band-pass (cutoff frequency10-400 Hz) and band-stop (cutoff frequency 59-61 Hz) filtered to remove movement artifact and 60 Hz electrical noise using dual-pass (zero phase lag) Butterworth filters. EMG data will then be full wave rectified and low pass filtered to create linear envelopes. Peak values will be extracted from the MVIC trials to be used for normalization of the running trials to express EMG data as % Maximum Voluntary Contraction (MVC). Root mean square (RMS) of each muscle's activity will be calculated during stance and swing phases of running to investigate amplitude differences. Cross-correlation methodology will be utilized to investigate relative timing between trunk and hip musculature. Comparisons will be made to assess symmetry of muscle activation amplitude and timing between intact and prosthetic limb sides for each of the running speed and prosthesis conditions.

Musculoskeletal Model Three musculoskeletal models will be developed in OpenSim. For the first model, the investigators will use a generic musculoskeletal model representing a non-amputee adult male, which has previously been used to assess muscle function during non-amputee running. The second and third models will be modified versions of the non-amputee model that represents a person using a prosthesis. The second model will include a traditional transtibial energy storage and return prosthesis, and the third model will include a running specific prosthesis. For both models, the investigators will remove the ankle muscles from the residual leg, including the medial and lateral gastrocnemius, soleus, tibialis posterior, flexor digitorum longus, tibialis anterior and extensor digitorum longus.

Running Simulation Generation The models will be scaled to each individual subject using manual, uniform scale factors, computed from an inverse dynamics model based on kinematic marker positions and developed in Visual3D (C-Motion, Inc., Germantown, MD). Then, an inverse kinematics solution will be computed in Visual3D using a weighted least squares optimization algorithm. After the inverse kinematics solution has been computed, the investigators will perform a Residual Reduction Algorithm. Once minor changes have been made to the model and to the kinematic trajectories of the generalized coordinates, the investigators will implement a Computed Muscle Control algorithm. Once a solution for individual muscle excitations is found using the Computed Muscle Control algorithm, the investigators will compare it to the experimentally-collected electromyographic data. The investigators will generate running simulations at all running speeds for all participants. The results of these simulations will be compared between groups and across speeds, similar to the experimental measures that will be analyzed in this study.

Joint Contact Force Analysis Once the running simulations have been developed, the three-dimensional contact load at the hip will be determined from the joint intersegmental force and compressive forces from the muscles crossing the joint, similar to the previous analyses during amputee walking. In addition, the muscle forces determined from the movement simulation will be used to help interpret the net contact loads.

Material Properties and Anthropometrics Inertial properties of the prosthetic components and intact body segments will be estimated for use with the inverse dynamics approach. Subject masses will be measured using a force platform. Height and body weight of each subject will be measured, and anthropometric measurements from marker positions will be used to estimate the mass, center of mass, and moments of inertia of intact limb segments. Because ILEA subjects are missing one foot and part of their shank, an adjusted body mass (ABM) will be used as an input to anthropometric regression equations that account for the missing body segments.

For subjects with amputation, the residual limb length and circumferences at the knee joint and distal end of the limb will be measured using a measuring tape. Residual limb inertial properties will then be estimated as a frustum of a right circular cone. Residual limb mass will be estimated from the calculated geometric volume assuming a uniform 1.10 g/cm3 tissue density. For the RSP conditions, the inertial properties of the RSP will be estimated from data published by the PI. Subsegments within the RSP keels will be defined via reflective marker placements and the inertial properties of each subsegment will be estimated by assuming each segment as a rigid trapezoidal cuboid. For the traditional prosthesis conditions, the inertial properties of the prosthesis will be estimated according to published literature.

  1. STATISTICAL PLAN and DATA ANALYSIS

Statistical Analysis This research is designed to determine the effects of prosthesis type on a variety of performance and injury-risk related outcome variables across a range of running speeds. A three factor (Group x Limb x Speed) mixed model ANOVA will be used to identify statistical changes of the following dependent variables: peak hip, knee, and ankle joint powers and mechanical work; average ground reaction forces; loading rates; and EMG amplitudes. Group (Individual Lower Extremity Amputation Running-Specific Prosthesis (ILEARSP) vs Individual Lower Extremity Amputation Traditional Prosthesis (ILEATrad) vs. Control) will be considered as a between-subjects independent variable, Limb (prosthetic/intact or left/right) as a within-subjects independent variable and Speed (2.5, 3.0, 3.5, 4.0, 5.0, and 6.0 m/s) as a within-subjects independent variable.

A two factor (Group x Speed) ANOVA will be used to identify statistical changes of dependent variables including ground reaction force symmetry, joint kinetic symmetry, and lumbopelvic kinematics. A one-way ANOVA will determine statistical differences between groups for the 50m dash time and speed.

Significance for all statistical tests will be set at α=0.05.

Sample Size Calculations This study will have appropriate statistical power to assess our hypotheses. Effect sizes for significant differences between RSP, intact, and able-bodied limbs in GRF loading rates, average GRF, and total joint work were estimated based on prior data collected by the PI from 8 ILEA and Control subjects running at 2.5, 3.0, and 3.5 m/s. These effect sizes ranged between 0.4 and greater than 0.9. An effect size of 0.7 was also estimated from the volume of oxygen (VO2) values of one study comparing subjects running with RSPs and traditional prostheses. To be conservative, the investigators utilized the lowest of these effect sizes (0.4) to perform a power analysis for ANOVA with repeated measures using G*Power (v. 3.1.9.2, Dusseldorf, Germany). This yielded a total sample size of 24 with α = 0.05 resulting in 80% power to detect differences between limbs, prosthetic feet, or ILEA and Control subjects in kinetic values during running. The investigators anticipate similar effect sizes for changes in the remaining biomechanical variables the investigators will examine in the proposed study. Based on this analysis, 12 ILEA subjects and 12 control subjects will provide substantial statistical power to detect significant differences in biomechanical outcomes between groups and prosthetic feet.

Being tested
Running on a treadmill at 6 different speeds
Keywords
Kinetics, Biomechanics, Amputation, Prosthesis, Transtibial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Running on a treadmill at 6 different speedsOther

    All subjects will be required to run at 6 prescribed speeds (2.5, 3.0, 3.5, 4.0, 5.0, and 6.0 m/sec) on a treadmill completing at least 10 consecutive strides, or running for 30 seconds.

Study groups in NCT02875197
Study groupRoleWhat they receive
Healthy ControlsMales and females 18-50 years old Up to 20 able-bodied sex, age, height, and weight-matched subjects
Receives: Other: Running on a treadmill at 6 different speeds
Lower Extremity AmputeesMales \& females 18-50 years old * Must have a unilateral, transtibial amputation \& must have been prescribed a running-specific prosthesis * Subject with amputations resulting from trauma, congenital reasons, or cancer treatment unless cancer is in remission or treatments do not impact gait function * Physician approval to run * 4 months experience using a running-specific prosthesis
Receives: Other: Running on a treadmill at 6 different speeds

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak Joint Powers

    Peak joint power, calculated as the product of joint torque and joint angular velocity, is the highest power value achieved during the movement being evaluated and is measured in watts or watts per kg if normalized based on body weight.

    Measured: Assessed on day 1 (data collection day)

  2. Concentric, Eccentric, and Total Joint and Limb Work.

    Concentric, eccentric, and total joint and limb work is defined as force multiplied by displacement, and is expressed in watts.

    Measured: Assessed on day 1 (data collection day)

  3. Average Ground Reaction Forces.

    Ground reaction force is the equaling and opposing force due to body mass passing through the foot to the ground surface; ground reaction forces is resolved into vertical (counteracting body weight) and horizontal (anterior and posterior) components. Ground reaction forces are expressed in newtons.

    Measured: Assessed on day 1 (data collection day)

  4. Ground Reaction Force Impulses

    Vertical and anteroposterior ground reaction force impulses are determined by multiplying the impact force by the time over which the impact force acts. Impulses are stated in newton-seconds.

    Measured: Assessed on day 1 (data collection day)

  5. Average Ground Reaction Force Magnitudes

    Ground reaction forces is defined as the force exerted by the ground on the body in contact with the ground. Ground reaction force magnitudes will be averaged and expressed in newtons.

    Measured: Assessed on day 1 (data collection day)

  6. Average Ground Reaction Force Loading Rates

    Ground reaction force loading rate is the speed at which forces impact the body, and is calculated by dividing the maximal vertical force by the time needed to reach the maximal vertical force. It is expressed in body weights per millisecond.

    Measured: Assessed on day 1 (data collection day)

  7. Ground Reaction Forces

    Asymmetry in ground reaction forces and joint moments is determined by statistical differences between the left and right side.

    Measured: Assessed on day 1 (data collection day)

  8. Normalized EMG Amplitudes

    EMG amplitudes will be measured in millivolts and then normalized based on EMG amplitudes measured during maximum voluntary contractions using a scale of 0 to 1.

    Measured: Assessed on day 1 (data collection day)

  9. Lumbopelvic Kinematics

    Lumbopelvic kinematics is a postural evaluation of the lumbopelvic region expressing positions in degrees or radians.

    Measured: Assessed on day 1 (data collection day)

  10. Joint Contact Forces over Stance

    Peak and average joint contact forces are forces that occur over stance (while there is contact between a limb and the ground). Peak forces are the highest force that occurs during stance, while average forces is the average of all force levels occuring during stance. Force measurements are expressed in newtons.

    Measured: Assessed on day 1 (data collection day)

  11. 50 Meter Dash

    A 50 meter dash effort will be used as an indicator of maximum running speed. It will be reported as an average of three trials and expressed as total time in seconds and as speed expressed in meters per second.

    Measured: Assessed on day 1 (data collection day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Aug 2016 (estimated)
  2. Study startAug 2016
  3. Primary completionSep 2018 (estimated)
  4. Study completionSep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02875197
Sponsor's protocol ID
OP140064
Status last verified
Sep 2017
First submitted
14 Jul 2016
Last updated
2 Oct 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Bussmann JB, Grootscholten EA, Stam HJ. Daily physical activity and heart rate response in people with a unilateral transtibial amputation for vascular disease. Arch Phys Med Rehabil. 2004 Feb;85(2):240-4. doi: 10.1016/s0003-9993(03)00485-4.

    PubMed 14966708
  • Naschitz JE, Lenger R. Why traumatic leg amputees are at increased risk for cardiovascular diseases. QJM. 2008 Apr;101(4):251-9. doi: 10.1093/qjmed/hcm131. Epub 2008 Feb 16.

    PubMed 18281705
  • Saris WH, Blair SN, van Baak MA, Eaton SB, Davies PS, Di Pietro L, Fogelholm M, Rissanen A, Schoeller D, Swinburn B, Tremblay A, Westerterp KR, Wyatt H. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev. 2003 May;4(2):101-14. doi: 10.1046/j.1467-789x.2003.00101.x.

    PubMed 12760445
  • Singh R, Hunter J, Philip A. The rapid resolution of depression and anxiety symptoms after lower limb amputation. Clin Rehabil. 2007 Aug;21(8):754-9. doi: 10.1177/0269215507077361.

    PubMed 17846075
  • Yap TL, Davis LS. Physical activity: the science of health promotion through tailored messages. Rehabil Nurs. 2008 Mar-Apr;33(2):55-62. doi: 10.1002/j.2048-7940.2008.tb00204.x.

    PubMed 18330383
  • Poirier P, Despres JP. Exercise in weight management of obesity. Cardiol Clin. 2001 Aug;19(3):459-70. doi: 10.1016/s0733-8651(05)70229-0.

    PubMed 11570117
  • Kavanagh T. Exercise and the heart. Ann Acad Med Singap. 1983 Jul;12(3):331-7.

    PubMed 6378048
  • Kram R, Grabowski AM, McGowan CP, Brown MB, Herr HM. Counterpoint: Artificial legs do not make artificially fast running speeds possible. J Appl Physiol (1985). 2010 Apr;108(4):1012-4; discussion 1014; author reply 1020. doi: 10.1152/japplphysiol.01238.2009a. No abstract available.

    PubMed 20368386
  • Weyand PG, Bundle MW. Point: Artificial limbs do make artificially fast running speeds possible. J Appl Physiol (1985). 2010 Apr;108(4):1011-2; discussion 1014-5. doi: 10.1152/japplphysiol.01238.2009. No abstract available.

    PubMed 20368385
  • Brown MB, Millard-Stafford ML, Allison AR. Running-specific prostheses permit energy cost similar to nonamputees. Med Sci Sports Exerc. 2009 May;41(5):1080-7. doi: 10.1249/MSS.0b013e3181923cee.

    PubMed 19346979
  • Baum BS. Kinetics in individuals with unilateral transtibial amputations using running-specific prostheses, Dissertation, University of Maryland, College Park, Md., 2012.

  • Grabowski AM, McGowan CP, McDermott WJ, Beale MT, Kram R, Herr HM. Running-specific prostheses limit ground-force during sprinting. Biol Lett. 2010 Apr 23;6(2):201-4. doi: 10.1098/rsbl.2009.0729. Epub 2009 Nov 4.

    PubMed 19889694
  • Sanderson DJ, Martin PE. Joint kinetics in unilateral below-knee amputee patients during running. Arch Phys Med Rehabil. 1996 Dec;77(12):1279-85. doi: 10.1016/s0003-9993(96)90193-8.

    PubMed 8976312
  • Czerniecki JM, Gitter A. Insights into amputee running. A muscle work analysis. Am J Phys Med Rehabil. 1992 Aug;71(4):209-18. doi: 10.1097/00002060-199208000-00003.

    PubMed 1642820
  • Czerniecki JM, Gitter A, Munro C. Joint moment and muscle power output characteristics of below knee amputees during running: the influence of energy storing prosthetic feet. J Biomech. 1991;24(1):63-75. doi: 10.1016/0021-9290(91)90327-j.

    PubMed 2026634

Questions about this trial

What is this clinical trial studying?

An observational study of Amputees and Running With Prosthesis, run by Regis University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Brian Baum, Ph.D. (303-964-6791, bbaum@regis.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak Joint Powers (time frame: Assessed on day 1 (data collection day)). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02875197, which also lists 50 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in